TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Viral diseases » Treatments
 

Treatments for Viral diseases

Treatments for Viral diseases

The list of treatments mentioned in various sources for Viral diseases includes the following list. Always seek professional medical advice about any treatment or change in treatment plans.

Medical news summaries about treatments for Viral diseases:

The following medical news items are relevant to treatment of Viral diseases:

Discussion of treatments for Viral diseases:

Viral diseases can be very difficult to treat because viruses live inside the body's cells where they are protected from medicines in the blood stream. Researchers developed the first antiviral drug in the late 20th century. The drug, acyclovir, was first approved by the U.S. Food and Drug Administration to treat herpes simplex virus infections. Only a few other antiviral medicines are available to prevent and treat viral infections and diseases.

Health care professionals treat HIV infection with a group of powerful medicines which can keep the virus in check. Known as highly active antiretroviral therapy, or HAART, the new treatment has improved the lives of many suffering from this deadly infection.

Viral diseases should never be treated with antibiotics. Sometimes a person with a viral disease will develop a bacterial disease as a complication of the initial viral disease. For example, children with chickenpox often scratch the skin sores caused by the viral infection. Bacteria such as staph can enter those lesions and cause a bacterial infection. The doctor may then prescribe an antibiotic to destroy the bacteria. The antibiotic, however, will not work on the chickenpox virus. It will work only against staph.

Unfortunately, safe and effective treatments and cures for most viral diseases have eluded researchers, but there are safe vaccines to protect you from viral infections and diseases. (Source: excerpt from Microbes in Sickness and in Health - Publications, National Institute of Allergy and Infectious Diseases: NIAID)

Buy Products Related to Treatments for Viral diseases

 
Shopping.com


Book Excerpts: Treatment of Viral diseases

Treatments of Viral diseases: Online Medical Books

16 MEDICAL BOOKS ONLINE! Review excerpts from medical books online, free, without registration, for more information about the treatments of Viral diseases.

Respiratory syncytial virus infection: Treatment
(Professional Guide to Diseases (Eighth Edition))

Treatment aims to support respiratory function, maintain fluid balance, and relieve symptoms. Ribavirin in aerosol form may be administered to severely ill patients or those at high risk for complications.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Ebola virus infection: Treatment
(Professional Guide to Diseases (Eighth Edition))

No cure exists for Ebola virus infection; treatment consists mainly of intensive supportive care. Administration of I.V. fluids helps offset the effects of severe dehydration. The patient may receive replacement of plasma heparin before the onset of clinical shock.

Experimental treatments include the administration of plasma that contains Ebola virus-specific antibodies. Although this treatment has resulted in diminished levels of Ebola virus in the body, further evaluation is needed.

Throughout treatment, the patient should remain on contact precautions. If diagnostic tests indicate that the patient is free from the virus — which typically occurs 21 days after onset in those few who survive — the patient can be released.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Viral hepatitis: Treatment
(Professional Guide to Diseases (Eighth Edition))

No specific drug therapy has been developed for hepatitis, with the exception of hepatitis C, which has been treated somewhat successfully with interferon alpha. Instead, patients are advised to rest in the early stages of the illness and to combat anorexia by eating small, high-calorie, high-protein meals. (Protein intake should be reduced if signs or symptoms of pre-coma — lethargy, confusion, and mental changes — develop.) Large meals are usually better tolerated in the morning because many patients experience nausea late in the day.

In acute viral hepatitis, hospitalization usually is required only for the patient with severe symptoms or complications. Parenteral nutrition may be required if the patient experiences persistent vomiting and is unable to maintain oral intake.

Antiemetics may be given 30 minutes before meals to relieve nausea and prevent vomiting; phenothiazines have a cholestatic effect and should be avoided. For severe pruritus, the resin cholestyramine may be given.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Respiratory syncytial virus infection: Treatment
(Handbook of Diseases)

Among the goals of treatment are support of respiratory function, maintenance of fluid balance, and relief of symptoms. Mild cases resolve without treatment. Severe infections require hospitalization to provide supplemental oxygen, humidified air, and hydration by I.V. fluids. Respiratory support using mechanical ventilation may be needed. Ribavirin aerosol may be used in those who have severe RSV or are immunocompromised.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Ebola virus infection: Treatment
(Handbook of Diseases)

No cure exists for Ebola virus disease; treatment consists mainly of intensive supportive care. The administration of I.V. fluids helps offset the effects of severe dehydration. Treatment of associated disseminated intravascular coagulation is controversial.

Experimental treatments include administration of plasma that contains Ebola virus–specific antibodies. Although this treatment has reduced levels of Ebola virus in the body, further evaluation is needed.

Throughout treatment, the patient should remain in isolation. If diagnostic tests indicate that the patient is free from the virus, which typically occurs 21 days after onset in those few who survive, the patient can be released.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Human immunodeficiency virus infection: Treatment
(Handbook of Diseases)

No cure has yet been found for the disorder; however, primary therapy for HIV infection includes three different types of antiretroviral agents:

❑ protease inhibitors (PIs), such as ritonavir, indinavir, nelfinavir, and saquinavir

❑ nucleoside reverse transcriptase inhibitors (NRTIs), such as zidovudine, didanosine, zalcitabine, lamivudine, and stavudine

❑ nonnucleoside reverse transcriptase inhibitors (NNRTIs), such as nevirapine and delavirdine.

These agents, used in various combinations, are designed to inhibit HIV viral replication. Other potential therapies include immunomodulatory agents designed to boost the weakened immune system and anti-infective and antineoplastic agents to combat opportunistic infections and associated cancers; some are used prophylactically to help patients resist opportunistic infections.

Current treatment protocols combine three agents in an effort to gain the maximum benefit with the fewest adverse reactions. Such regimens include one PI and are considered the most effective treatment. Many variations and drug interactions are under study. Combination therapy helps inhibit the production of resistant, mutant strains. Supportive treatments help maintain nutritional status and relieve pain and other distressing physical and psychological symptoms.

Many pathogens respond to anti-infective drugs but tend to recur after treatment ends. For this reason, most patients need continuous anti-infective treatment, presumably for life or until the drug is no longer tolerated or effective.

UNDER STUDY: Once-daily dosing with antiretroviral drugs, such as didanosine, efavirenz, lamivudine, and tenofovir, to increase treatment adherence to drug-resistant variants of HIV is under investigation. A combination of amprenavir, a protease inhibitor, boosted with ritonavir has been approved, and other new antiretroviral drugs are currently in development for new dosing schedules.

Zidovudine

Treatment with zidovudine has proven effective in slowing the progression of HIV infection, decreasing opportunistic infections, and prolonging survival. However, it commonly produces serious adverse reactions and toxicities. The drug is typically combined with other agents (such as lamivudine) but has also been used as a single agent for pregnant HIV-positive women.

The current recommendation is to take 100 mg every 4 hours for a total daily dose of 600 mg, or 500 mg if the patient doesn’t want to interrupt sleep. Other NRTIs, such as didanosine and zalcitabine, may also be used in combination regimens for patients who can’t tolerate or no longer respond to zidovudine.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Hepatitis, viral: Treatment
(Handbook of Diseases)

No specific drug therapy has been developed for hepatitis, with the exception of hepatitis C, which has been treated somewhat successfully with interferon alfa-2b and the more recently FDA-approved peginterferon alfa-2a. Instead, the patient is advised to rest in the early stages of the illness and to combat anorexia by eating small, high-protein meals.

Clinical tip  The largest meal should be eaten in the morning because nausea tends to intensify as the day progresses.

Protein intake should be reduced if signs of precoma — lethargy, confusion, and mental changes — develop.

In acute viral hepatitis, hospitalization is usually required only for patients with severe symptoms (severe nausea, vomiting, change in mental status, and PT greater than 3 seconds above normal) or complications. Parenteral nutrition may be required if the patient experiences persistent vomiting and can’t maintain oral intake.

Antiemetics (diphenhydramine or prochlorperazine) may be given 30 minutes before meals to relieve nausea and prevent vomiting; phenothiazines have a cholestatic effect and should be avoided. For severe pruritus, the resin cholestyramine may be given.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003



 » Next page: Doctors and Medical Specialists for Viral diseases

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

Tools & Services:

Medical Articles:

Forums & Message Boards

 
HONcode We subscribe to the HONcode principles

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise